Reason for withdrawal from publication
Cochrane Schizophrenia Group internal peer review complete (see Module). External peer review scheduled.
This review has been updated and replaced by
Komossa K, Rummel‐Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S. Risperidone versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews 2007 , Issue 3 . Art. No.: CD006626. DOI: 10.1002/14651858.CD006626 .
The editorial group responsible for this previously published document have withdrawn it from publication.
Feedback
Results and Dicussion
Summary
The commentator notes that the Results and Discussion sections are inconsistent regarding the outcomes of agitation and constipation for the comparison of risperidone and amisulpiride.
Contributors
Comment submitted by Ruth Lopert, Newcastle, Australia, October 2000.
What's new
| Date | Event | Description |
|---|---|---|
| 13 January 2011 | Amended | Has been replaced by newer review of same title by K.Komossa |
History
Review first published: Issue 3, 2000
| Date | Event | Description |
|---|---|---|
| 15 February 2010 | Amended | Contact details updated. |
| 31 October 2008 | Amended | Converted to new review format. |
Sources of support
Internal sources
NHS Centre for Reviews and Dissemination, UK.
Medical Research Council Fellowship Programme, UK.
NHS Health Technology Assessment Programme, UK.
St Andrew's Hospital, UK.
Helsinki University Central Hospital (HUCH), Finland.
External sources
Finska Läkaresällskapet (Finnish Medical Society), Finland.
National Research and Development Centre for Welfare and Health (STAKES), Finland.
Withdrawn from publication for reasons stated in the review